Related Experiment Video

Updated: Apr 3, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

19.7K

Natural killer cell receptors: alterations and therapeutic targeting in malignancies

Gordana Konjević1,2, Ana Vuletić3, Katarina Mirjačić Martinović3

  • 1Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, 14 Pasterova, Belgrade, 11000, Serbia. konjevicg@ncrc.ac.rs.

Immunologic Research
|September 17, 2015
PubMed

Insights

Understanding Natural Killer (NK) cell receptor biology is crucial for cancer immunotherapy. Manipulating NK cell activity through various strategies enhances their antitumor functions, offering new treatment avenues.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Therapeutics

Background:

  • Natural Killer (NK) cell antitumor activity is regulated by activating and inhibitory receptors interacting with tumor cell ligands.
  • Dysregulation of NK cell receptor expression and signaling impairs their cytotoxic function.
  • Cytokines like Interferon-alfa (IFN-α), Interleukin-2 (IL-2), IL-12, IL-15, and IL-18 can enhance NK cell antitumor responses.

Purpose of the Study:

  • To explore the role of NK cell receptor biology in regulating antitumor activity.
  • To review current and novel strategies for enhancing NK cell-based cancer immunotherapy.
  • To highlight the need for a deeper understanding of NK cell receptor mechanisms for therapeutic development.

Main Methods:

  • Review of scientific literature on NK cell receptor function and cancer immunotherapy.
  • Analysis of the impact of cytokines and pharmacological agents on NK cell activity.
  • Examination of immunotherapeutic approaches involving KIR/HLA mismatch in stem cell transplantation.

Main Results:

  • Cytokines enhance NK cell antitumor activity by upregulating activating receptors and cytotoxic molecules.
  • Pharmacological agents can increase tumor cell ligands for NK cell activating receptors, improving response.
  • Allogeneic stem cell transplantation strategies leverage NK cell activity for graft-versus-tumor effects.

Conclusions:

  • A comprehensive understanding of NK cell activating and inhibitory receptor biology is essential for advancing cancer immunotherapy.
  • Targeted manipulation of NK cells holds significant promise for developing effective cancer treatments.
  • Further research into NK cell receptor interactions can lead to novel immunotherapeutic strategies.
Keywords:
Cancer immunotherapyNK cell inhibitory and activating receptorsNK cells

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

22.2K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

2.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.3K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
10.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.9K